Texas Bank & Trust Co Acquires Shares of 2,602 UnitedHealth Group Incorporated (NYSE:UNH)

Texas Bank & Trust Co acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 2,602 shares of the healthcare conglomerate’s stock, valued at approximately $1,316,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the 4th quarter worth $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday. Morgan Stanley reduced their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Robert W. Baird cut their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a report on Thursday. Six equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $486.00.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John H. Noseworthy acquired 300 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now directly owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 6.2%

UNH stock opened at $291.24 on Friday. The stock’s 50 day simple moving average is $470.82 and its 200 day simple moving average is $513.60. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $264.20 billion, a P/E ratio of 18.79, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company posted $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.